Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A8313 RAF265Target: Raf|VEGFRSummary: Multiple intracellular kinases inhibitor -
A8319 Dacomitinib (PF299804, PF299)Target: ErbBSummary: HER inhibitor -
A8320 PF-00562271Target: FAK|Pyk2Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive -
A8322 Neratinib (HKI-272)3 CitationTarget: EGFRSummary: HER2/EGFR inhibitor,potent and irreversible -
A8324 LDN-1931898 CitationTarget: BMP and Other Activin ReceptorsSummary: ALK inhibitor,potent and selective -
A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met inhibitor,non-ATP-competitive -
A8328 LDK378Target: ALKSummary: Potent ALK inhibitor -
A8332 R788 disodiumTarget: SykSummary: Syk inhibitor,ATP competitive and potent -
A8334 Linsitinib3 CitationSummary: IGF1R/IR inhibitor,potent and novel -
A8350 AZD4547Target: FGFRSummary: FGFR inhibitor

